1. Home
  2. SHPH vs RELI Comparison

SHPH vs RELI Comparison

Compare SHPH & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • RELI
  • Stock Information
  • Founded
  • SHPH 2012
  • RELI 2013
  • Country
  • SHPH United States
  • RELI United States
  • Employees
  • SHPH N/A
  • RELI N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • RELI Specialty Insurers
  • Sector
  • SHPH Health Care
  • RELI Finance
  • Exchange
  • SHPH Nasdaq
  • RELI Nasdaq
  • Market Cap
  • SHPH 3.1M
  • RELI 3.5M
  • IPO Year
  • SHPH 2022
  • RELI N/A
  • Fundamental
  • Price
  • SHPH $1.17
  • RELI $2.33
  • Analyst Decision
  • SHPH
  • RELI Strong Buy
  • Analyst Count
  • SHPH 0
  • RELI 1
  • Target Price
  • SHPH N/A
  • RELI $119.00
  • AVG Volume (30 Days)
  • SHPH 141.0K
  • RELI 211.3K
  • Earning Date
  • SHPH 11-12-2024
  • RELI 11-11-2024
  • Dividend Yield
  • SHPH N/A
  • RELI N/A
  • EPS Growth
  • SHPH N/A
  • RELI N/A
  • EPS
  • SHPH N/A
  • RELI N/A
  • Revenue
  • SHPH N/A
  • RELI $13,912,598.00
  • Revenue This Year
  • SHPH N/A
  • RELI N/A
  • Revenue Next Year
  • SHPH N/A
  • RELI N/A
  • P/E Ratio
  • SHPH N/A
  • RELI N/A
  • Revenue Growth
  • SHPH N/A
  • RELI 7.09
  • 52 Week Low
  • SHPH $1.13
  • RELI $2.12
  • 52 Week High
  • SHPH $5.35
  • RELI $43.69
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 30.09
  • RELI 39.43
  • Support Level
  • SHPH $1.29
  • RELI $2.17
  • Resistance Level
  • SHPH $1.37
  • RELI $2.57
  • Average True Range (ATR)
  • SHPH 0.12
  • RELI 0.21
  • MACD
  • SHPH 0.01
  • RELI 0.01
  • Stochastic Oscillator
  • SHPH 4.93
  • RELI 33.93

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: